Abstract
However, how to identify organ perfusion abnormalities at the bedside and select the type and amount of fluids required to improve tissue hypoxia remain highly controversial. Traditionally, clinical signs, such as reduced blood pressure and urinary output, altered consciousness, and mottled skin, have been used to identify tissue perfusion abnormalities. Consequently, current hemodynamic monitoring during shock states mainly focuses on detection of pressure-derived hemodynamic variables related to systemic circulation. However, it has been largely recognized that monitoring these macro-hemodynamic variables is not sufficient to rule out persistent abnormalities of tissue oxygenation. Indeed, the usefulness of resuscitation targets, such as global oxygen-derived parameters, has been strongly questioned,
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have